bioRxiv Science⌕ Search

bioRxiv · 10.1101/2025.09.11.675502

Spatiotemporal dynamics of alphaherpesviral latency and reactivation in the murine central nervous system

Abstract

Alphaherpesviruses, including Herpes Simplex Virus 1 (HSV-1) and Pseudorabies Virus (PrV), establish lifelong latency in the nervous system and can cause recurrent disease. While latency has classically been attributed to peripheral sensory ganglia, accumulating evidence indicates that the central nervous system (CNS) also act as a relevant reservoir for viral latency and reactivation. Here, we investigated the CNS as a site of latency using the attenuated mutant PrV-{Delta}UL21/US3{Delta}kin which reproduces key features of herpes simplex encephalitis (HSE) in female CD1 mice. We mapped brain regions permissive to alphaherpesviral latency and analyzed the temporal dynamics of viral transcription, histopathology, and host clinical and immune responses. Following intranasal inoculation, mice were analyzed at 11 to 14, 21, 28, 42, 105, and 190 days post infection (dpi). To assess the potential of reactivation, a subset received cyclophosphamide/dexamethasone at 170 dpi. Viral transcripts were detected by RNAscope in situ hybridization and RT-qPCR targeting the lytic gene UL19 and the latency-associated transcript (LAT). Histopathological analyses included hematoxylin and eosin (H&E) staining and immunohistochemistry for CD3, Iba1, GFAP, and cleaved caspase-3. Major capsid protein (UL19) expression displayed marked regional and temporal heterogeneity, with prominent signals in mesiotemporal structures (piriform cortex, hippocampus, entorhinal cortex), coinciding with pronounced T-cell infiltration. LAT expression remained overall low, with a transient peak during the acute infection (11-14 dpi). RT-qPCR confirmed high viral transcript levels for both UL19 and LAT in mesiotemporal regions during early infection, while LAT expression returned to baseline levels thereafter. Histopathology demonstrated a transition from acute necrotizing meningoencephalitis to prolonged or recurrent low-grade inflammation, accompanied by glial activation and localized apoptosis. Notably, UL19 expression strongly correlated with CD3+ T-cell infiltration, particularly at 42 dpi. These findings define the spatiotemporal interplay between viral transcriptional activity and neuroinflammation and identify selected CNS regions as reservoirs for latent or recurrent alphaherpesvirus infection. Author SummaryAlphaherpesviruses are pathogens that not only cause acute disease but also establish lifelong latency in the nervous system. Under certain conditions, they can reactivate and trigger recurrent disease. Using a genetically modified pseudorabies virus in mice, we mapped how latent and lytic phases occur within the brain over several months. By combining molecular, histological, and clinical analyses, we show that specific brain regions act as long-term viral reservoirs, where signs of inflammation and viral activity can reappear long after the initial infection. These findings provide new insights into how alphaherpesviruses persist in the central nervous system and suggest that recurrent or subclinical reactivation may contribute to long-term neurological complications, including those resembling human herpes simplex encephalitis.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Korff, V., El-Debs, I., Klupp, B. G., Teifke, J. P., Mettenleiter, T. C., Sehl-Ewert, J.. 2025-09-16. Spatiotemporal dynamics of alphaherpesviral latency and reactivation in the murine central nervous system. https://doi.org/10.1101/2025.09.11.675502

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

Neurodegeneration-inducing macromolecules exit the brain via nanovascular conduits formed by reticular fibroblasts

Accumulation of proteins such as amyloid beta (Abeta), hyperphosphorylated tau and alpha-synuclein within the brain alters neural information processing and causes neurodegeneration(1-3), but how toxic solutes are cleared from the brain remains highly controversial(4,5). Proposed exit routes include efflux across endothelial cells into the blood(6,7), and movement to the pial surface via vasomotion-induced pumping along spaces within arteriolar smooth muscle(8) or via outflow along the perivascular space of ascending venules promoted by water flux through astrocytes (the glymphatic system(9)). From the pial surface of the brain, drainage may continue to dural lymphatics, along the outer sheaths of exiting cranial nerves and across the cribriform plate(10-14). We now report the presence, in mice and humans, of 2 micron diameter conduits that remove fluorescently labelled tau and Abeta from the brain. These conduits form a spatially-organised mesh within the walls of penetrating arterioles and pial arteries, and around the surface of ascending venules and deep cerebral and pial veins. They course through the pial and arachnoid layers to span the CSF space, wrapping the brain and cranial nerves. They are formed of reticular fibroblasts, which label for VE-cadherin(15) and PDGFRalpha(16), the lymphatic markers(17) podoplanin, VEGFR3 and Prox1, and reticular fibroblast extracellular matrix components collagen I and VI(16,18-20). Parenchymal tau drains from the brain at a similar rate via arteriolar conduits and via conduits around venules, arguing against preferential removal by a glymphatic mechanism. In Alzheimer's disease model mice, Abeta is seen traversing these lymph node-like conduits. Modulation of molecular transfer via this route may accelerate or delay cognitive decline, and slowed transfer from arteriolar to pial-arachnoid conduits may initiate cerebral amyloid angiopathy.

neuroscience↗

Analysis of the influence of gradual changes in matrix sentence similarity on neural envelope tracking

Neural tracking of speech is a well-established phenomenon in neuroscience. However, for speech signals with a fixed structure, significant correlations between speech envelopes and neurophysiological representations occur even for unheard sentences. We exploit a structured speech-in-noise matrix hearing test (Oldenburger Sentence Test, OLSA) to systematically quantify the relationship between acoustic sentence similarity and neural tracking. Simultaneous magnetoencephalography (MEG) and 76-channel electroencephalography (EEG) data, including 16 channels positioned directly around the ears (ear-EEG), were recorded from 21 young adults with normal hearing during the presentation of clean-speech audiobooks and OLSA sentences at six signal-to-noise ratios. A linear decoder trained on audiobooks reconstructed OLSA sentence envelopes. Reconstruction accuracies were compared using a linear mixed model across heard (matched) and unheard (mismatched) sentences of varying acoustic similarity. Significant reconstruction accuracies were achieved across MEG, EEG, and ear-EEG for both matched and mismatched sentences. For mismatched sentences, these accuracies gradually increased with their acoustic similarity to the heard speech data. The high similarity between sentences, which is especially prominent in matrix tests, can cause significant spurious tracking for mismatched stimuli. This effect can reach levels comparable to those of matched sentences and can be mistaken for true neural tracking. Robust neural tracking across modalities further supported the established viability of ear-EEG compared to whole-head systems.

neuroscience↗

Seizures and tauopathy following neurotrauma are mediated by prion protein and metabotropic glutamate receptor 5

Traumatic brain injury (TBI) is one of the world's leading causes of death and disability and a major risk factor for dementias. The primary dementia associated with TBI is chronic traumatic encephalopathy (CTE), a neurodegenerative disease classified as a tauopathy, in which toxic tau molecules lead to disease pathologies and degeneration. The processes that lead to tauopathy and subsequent dementia after TBI remain unclear. Here, we built upon the finding that seizures after TBI may be a mechanism leading to tauopathy, by dissecting the functions of the metabotropic glutamate receptor 5 - cellular prion protein (mGluR5-PrPC) pathway. We delivered TBI to larval in a blast paradigm, and quantified aggregation of Tau via a genetically-encoded Tau-GFP fusion reporter. Zebrafish larvae lacking prp2 (homolog of mammalian cellular Prion Protein, PrPC) displayed a 168% increase in post-traumatic seizures activity after TBI. An mGluR5 agonist (CHPG) reduced post-traumatic seizures, whereas an mGluR5 antagonist (MPEP) increased post-traumatic seizures. Moreover, agonizing mGluR5 reduced tau aggregation and antagonizing mGluR5 increased tau burden. Larvae seizing from convulsants, rather than TBI, were treated with CHPG/MPEP and provided a similar pattern of outcomes, suggesting seizures may be a factor needed for mGluR5 activity to influence tau aggregation. The PrPC-mGluR5 pathway is proposed as one candidate pathomechanism linking TBI to subsequent seizures and tauopathy, and thus it warrants investigation as a target for prophylactic interventions.

neuroscience↗